Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

MIRM - Mirum Pharmaceuticals Inc


IEX Last Trade
43.11
1.130   2.621%

Share volume: 331,362
Last Updated: Fri 30 Aug 2024 09:59:58 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%

$41.98
1.13
2.69%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31
Fiscal Quarter Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024
Report Date 2022-08-04 2022-11-09 2023-03-08 2023-05-04 2023-08-07 2023-11-02 2024-03-15 2024-05-08
Total revenue 17.484 M 18.780 M 27.906 M 31.598 M 37.497 M 47.725 M 69.554 M 69.222 M
Cost of revenue 2.524 M 2.932 M 4.494 M 4.979 M 6.812 M 10.228 M 25.020 M 17.830 M
Gross profit 14.960 M 15.848 M 23.412 M 26.619 M 30.685 M 37.497 M 44.534 M 51.392 M
    5.94% 47.73% 13.70% 15.27% 22.20% 18.77% 15.40%  
Operating expenses 46.401 M 48.730 M 57.573 M 53.767 M 54.958 M 62.645 M 77.119 M 77.860 M
Selling general and admin 20.969 M 22.513 M 26.468 M 30.219 M 32.949 M 36.528 M 46.184 M 45.638 M
Research and development 25.432 M 26.217 M 31.105 M 23.548 M 22.009 M 26.117 M 30.935 M 32.222 M
Total expenses 48.925 M 51.662 M 62.067 M 58.746 M 61.770 M 72.873 M 102.139 M 95.690 M
    5.59% 20.14% -5.35% 5.15% 17.97% 40.16% -6.31%  
Operating income -31.441 M -32.882 M -34.161 M -27.148 M -24.273 M -25.148 M -32.585 M -26.468 M
Ebit -31.441 M -32.882 M -34.161 M -27.148 M -24.273 M -25.148 M -32.585 M -26.468 M
Pretax income -33.492 M -35.693 M -36.291 M -29.929 M -73.722 M -23.339 M -35.434 M -24.655 M
    6.57% 1.68% -17.53% 146.32% -68.34% 51.82% -30.42%  
Income tax -6.570 M 13.000 K 140.000 K 201.000 K 316.000 K 249.000 K 225.000 K 624.000 K
Net income basic -26.922 M -35.706 M -36.431 M -30.130 M -74.038 M -23.588 M -35.659 M -25.279 M
    -32.63% -2.03% 17.30% -145.73% 68.14% -51.17% 29.11%  
Net income -26.922 M -35.706 M -36.431 M -30.130 M -74.038 M -23.588 M -35.659 M -25.279 M
    -32.63% -2.03% 17.30% -145.73% 68.14% -51.17% 29.11%